| Waubonsie Mental Health Center Inc | |
|
216 W Division St Clarinda IA 51632-2509 | |
| (712) 542-2388 | |
| (712) 542-2984 |
| Full Name | Waubonsie Mental Health Center Inc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 216 W Division St, Clarinda, Iowa |
| Authorized Official Name and Position | Brian Shotwell (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 7125422388 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Waubonsie Mental Health Center Inc 216 W Division St Clarinda IA 51632-2509 Ph: (712) 542-2388 | Waubonsie Mental Health Center Inc 216 W Division St Clarinda IA 51632-2509 Ph: (712) 542-2388 |
| NPI Number | 1376698837 |
|---|---|
| Provider Enumeration Date | 01/24/2007 |
| Last Update Date | 02/06/2019 |
| Medicare PECOS PAC ID | 1658262415 |
|---|---|
| Medicare Enrollment ID | O20040322001214 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376698837 | NPI | - | NPPES |
| 0017244 | Medicaid | IA | |
| 0229419 | Medicaid | IA | |
| 0299446 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (Iowa) | Primary |
| Provider Name | Stephanie R Gray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598786097 PECOS PAC ID: 2466426697 Enrollment ID: I20040824000448 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Carla K. Abel-zieg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356564371 PECOS PAC ID: 2062323017 Enrollment ID: I20050510000128 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Cyd Q Grafft |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477633188 PECOS PAC ID: 2264565589 Enrollment ID: I20100805001109 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Michael L Egger |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144370131 PECOS PAC ID: 1557486610 Enrollment ID: I20100923000613 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Susan L Ecker |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1386765576 PECOS PAC ID: 2163529462 Enrollment ID: I20120221000477 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Megan L Mortensen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871926766 PECOS PAC ID: 2668607219 Enrollment ID: I20131106001723 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Luanne M Even |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1073866075 PECOS PAC ID: 9739499385 Enrollment ID: I20151110002535 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Denise Crosson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063497469 PECOS PAC ID: 3476579053 Enrollment ID: I20170809002513 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Michele Marie Barnett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326556713 PECOS PAC ID: 9537420740 Enrollment ID: I20180921002135 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Emily Kathryn Barnett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457851271 PECOS PAC ID: 4284996612 Enrollment ID: I20190219000825 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Marcy Taylor |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326660937 PECOS PAC ID: 6103284674 Enrollment ID: I20230615003015 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Debra L Arbuckle |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1174233076 PECOS PAC ID: 5890157887 Enrollment ID: I20230808000898 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Austin L Barth |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1730858739 PECOS PAC ID: 8325482714 Enrollment ID: I20240213003587 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
| Provider Name | Kimberly K Durbin |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1104303759 PECOS PAC ID: 8921442310 Enrollment ID: I20240213003705 |
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
News Archive
A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.
As patients become more engaged in decisions related to treatment and health care, their role in holding down health care spending will likely become more prominent.
The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."
New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. announced today that, as a result of the newly formed alliance Regulus has established with sanofi-aventis, each company will receive a payment of $1.8 million from Regulus. This represents 7.5% of the $25 million upfront payment from sanofi-aventis to Regulus.
› Verified 5 days ago
Southwest Iowa Families Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 215 E Washington St, Clarinda, IA 51632 Phone: 712-542-3501 Fax: 712-542-4725 | |
Harbor Point Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 218 W Division St, Clarinda, IA 51632 Phone: 712-850-1389 Fax: 712-215-7184 |